Dr. Gol Minoo Golshani, MD

Dr. Golshani practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Golshani's NPI, 1629497797, was assigned on April 15, 2014. Dr. Golshani graduated from St. George's University School of Medicine in 2014. Dr. Golshani holds California license A170977.

Dr. Golshani's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Golshani's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Golshani is also affiliated with Providence Mission Hospital. The medical group on file is UCI Health Physicians. Dmand AI also links Dr. Golshani to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golshani practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Golshani's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Golshani is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Golshani's licenses on file in 2 states: California and New York.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, fluid and electrolyte imbalances, lymphoma and neutropenia among the conditions Dr. Golshani treats.

CMS data shows 1,991 Medicare services from Dr. Golshani across 14 procedure codes in 2024, for 162 Medicare patients. Medicare paid $29,784 for them. Every service was in an office.

CMS counts 162 Medicare patients who saw Dr. Golshani in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 72% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Golshani's median patient age at 63, with 60% women.

In 2024, Dr. Golshani wrote 984 Medicare Part D claims for 179 patients. 71% of them were for generic drugs. CMS names the drug for 652 of them, across 23 drugs with 11 or more claims each, at $2,251,182 in total drug cost. In 2023, CMS named 663 claims across 24 drugs.

Dr. Golshani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Golshani as offering telehealth.

Dmand AI links 4 papers to Dr. Golshani, published from 2019 to 2020. 2020 was the busiest year, with 3. Dr. Golshani's most frequent co-authors are Amna Falak Sher, MD and Shenhong Wu, MD.

CMS Open Payments shows 500 general payments to Dr. Golshani from 60 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 85% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,322.

Dr. Golshani graduated from St. George's University School of Medicine in 2014.

Dr. Golshani is in network with 10 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Humana. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.